[1] |
FLORES-MIRELES A L, WALKER J N, CAPARON M, et al. Urinary tract infections:epidemiology,mechanisms of infection and treatment options[J]. Nat Rev Microbiol, 2015, 13(5):269-284.
DOI
URL
|
[2] |
CHAKRABORTY A, ADHIKARI P, SHENOY S, et al. Molecular characterisation of uropathogenic Escherichia coli isolates at a tertiary care hospital in South India[J]. Indian J Med Microbiol, 2017, 35(2):305-310.
DOI
URL
|
[3] |
BAUCKMAN K A, MYSOREKAR I U. Ferritinophagy drives uropathogenic Escherichia coli persistence in bladder epithelial cells[J]. Autophagy, 2016, 12(5):850-863.
DOI
URL
|
[4] |
LUO Y, MA Y, ZHAO Q, et al. Similarity and divergence of phylogenies,antimicrobial susceptibilities,and virulence factor profiles of Escherichia coli isolates causing recurrent urinary tract infections that persist or result from reinfection[J]. J Clin Microbiol, 2012, 50(12):4002-4007.
DOI
URL
|
[5] |
CLERMONT O, BONACORSI S, BINGEN E. Rapid and simple determination of the Escherichia coli phylogenetic group[J]. Appl Environ Microbiol, 2000, 66(10):4555-4558.
DOI
URL
|
[6] |
JOHNSON J R, STELL A L. Extended virulence genotypes of Escherichia coli strains from patients with urosepsis in relation to phylogeny and host compromise[J]. J Infect Dis, 2000, 181(1):261-272.
DOI
URL
|
[7] |
YUN K W, KIM D S, KIM W, et al. Molecular typing of uropathogenic Escherichia coli isolated from Korean children with urinary tract infection[J]. Korean J Pediatr, 2015, 58(1):20-27.
DOI
URL
|
[8] |
LEE J H, SUBHADRA B, SON Y J, et al. Phylogenetic group distributions,virulence factors and antimicrobial resistance properties of uropathogenic Escherichia coli strains isolated from patients with urinary tract infections in South Korea[J]. Lett Appl Microbiol, 2016, 62(1):84-90.
DOI
URL
|
[9] |
RUSSO T A, CARLINO U B, JOHNSON J R. Identification of a new iron-regulated virulence gene,ireA,in an extraintestinal pathogenic isolate of Escherichia coli[J]. Infect Immun, 2001, 69(10):6209-6216.
DOI
URL
|
[10] |
GUGLIETTA A. Recurrent urinary tract infections in women:risk factors,etiology,pathogenesis and prophylaxis[J]. Future Microbiol, 2017, 12:239-246.
DOI
URL
|
[11] |
SCHREIBER H L 4th, CONOVER M S, CHOU W C, et al. Bacterial virulence phenotypes of Escherichia coli and host susceptibility determine risk for urinary tract infections[J]. Sci Transl Med, 2017, 9(382):eaaf1283.
|
[12] |
CAO X, CAVACO L M, LV Y, et al. Molecular characterization and antimicrobial susceptibility testing of Escherichia coli isolates from patients with urinary tract infections in 20 Chinese hospitals[J]. J Clin Microbiol, 2011, 49(7):2496-2501.
DOI
URL
|
[13] |
CHEN S L, HUNG C S, XU J, et al. Identification of genes subject to positive selection in uropathogenic strains of Escherichia coli:a comparative genomics approach[J]. Proc Natl Acad Sci U S A, 2006, 103(15):5977-5982.
DOI
URL
|
[14] |
LE GALL T, CLERMONT O, GOURIOU S, et al. Extraintestinal virulence is a coincidental by-product of commensalism in B2 phylogenetic group Escherichia coli strains[J]. Mol Biol Evol, 2007, 24(11):2373-2384.
DOI
URL
|
[15] |
O'BRIEN V P, HANNAN T J, NIELSEN H V, et al. Drug and Vaccine Development for the Treatment and Prevention of Urinary Tract Infections[J]. Microbiol Spectr, 2016, 4(1).
|
[16] |
REIGSTAD C S, HULTGREN S J, GORDON J I. Functional genomic studies of uropathogenic Escherichia coli and host urothelial cells when intracellular bacterial communities are assembled[J]. J Biol Chem, 2007, 282(29):21259-21267.
DOI
URL
|
[17] |
LO A W, MORIEL D G, PHAN M D, et al. 'Omic' approaches to study uropathogenic Escherichia coli virulence[J]. Trends Microbiol, 2017, 25(9):729-740.
DOI
URL
|
[18] |
TERLIZZI M E, GRIBAUDO G, MAFFEI M E. Uropathogenic Escherichia coli(UPEC) infections:virulence factors,bladder responses,antibiotic,and non-antibiotic antimicrobial strategies[J]. Front Microbiol, 2017, 8:1566.
DOI
URL
|
[19] |
RAHDAR M, RASHKI A, MIRI H R, et al. Detection of pap,sfa,afa,foc,and fim adhesin-encoding operons in uropathogenic Escherichia coli isolates collected from patients with urinary tract infection[J]. Jundishapur J Microbiol, 2015, 8(8):e22647.
|
[20] |
DOYE A, METTOUCHI A, BOSSIS G, et al. CNF1 exploits the ubiquitin-proteasome machinery to restrict Rho GTPase activation for bacterial host cell invasion[J]. Cell, 2002, 111(4):553-564.
DOI
URL
|
[21] |
RIPPERE-LAMPE K E, O'BRIEN A D, CONRAN R, et al. Mutation of the gene encoding cytotoxic necrotizing factor type 1(cnf1) attenuates the virulence of uropathogenic Escherichia coli[J]. Infect Immun, 2001, 69(6):3954-3964.
DOI
URL
|
[22] |
WANG Y, ZHAO S, HAN L, et al. Drug resistance and virulence of uropathogenic Escherichia coli from Shanghai,China[J]. J Antibiot(Tokyo), 2014, 67(12):799-805.
|
[23] |
WAGENLEHNER F M, WULLT B, PERLETTI G. Antimicrobials in urogenital infections[J]. Int J Antimicrob Agents, 2011, 38 Suppl: 3-10.
DOI
URL
|
[24] |
NABER K G, SCHITO G, BOTTO H, et al. Surveillance study in Europe and Brazil on clinical aspects and Antimicrobial Resistance Epidemiology in Females with Cystitis(ARESC):implications for empiric therapy[J]. Eur Urol, 2008, 54(5):1164-1175.
DOI
URL
|